Your browser doesn't support javascript.
loading
Seguimiento de 20 pacientes portadores de fibrosis pulmonar idiopática tratados con nintedanib / Follow-up of 20 patients with idiopathic pulmonary fibrosis treated with nintedanib
Undurraga P, Alvaro.
Affiliation
  • Undurraga P, Alvaro; Instituto Nacional del Tórax. Santiago. CL
Rev. chil. enferm. respir ; 38(3): 160-167, sept. 2022. tab, graf
Article in Es | LILACS | ID: biblio-1423697
Responsible library: CL126.2
RESUMEN
Se presenta un estudio observacional compasivo de seguimiento de 20 pacientes portadores de Fibrosis Pulmonar Idiopática tratados con Nintedanib, que muestra que Nintedanib es un medicamento en general bien tolerado, sin efectos adversos serios, que otorga una sobrevida más prolongada que la que cabría esperar en pacientes con esta enfermedad.
ABSTRACT
A compassionate observational follow-up study of 20 patients with Idiopathic Pulmonary Fibrosis treated with Nintedanib is presented, showing that Nintedanib is a generally well-tolerated drug, with no serious adverse effects, that grants a longer survival in real-life patients.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: 1 Index: LILACS Main subject: Protein Kinase Inhibitors / Idiopathic Pulmonary Fibrosis / Indoles Type of study: Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male Language: Es Journal: Rev. chil. enferm. respir Journal subject: PNEUMOLOGIA Year: 2022 Type: Article
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: 1 Index: LILACS Main subject: Protein Kinase Inhibitors / Idiopathic Pulmonary Fibrosis / Indoles Type of study: Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male Language: Es Journal: Rev. chil. enferm. respir Journal subject: PNEUMOLOGIA Year: 2022 Type: Article